# BELRAPZO

NDC: 42367-521
Generic name: bendamustine hydrochloride
Labeler / Manufacturer: Eagle Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20190603

FDA application: NDA205580

## Active ingredients

- BENDAMUSTINE HYDROCHLORIDE: 100 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42367-521"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42367-521
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9759a4ae-82ca-40cf-9c02-e1cadb21cbdc